Medibank FY26 underlying NPAT rises 2.9% to $636.8 million

• Medibank posted FY26 NPAT attributable to shareholders of AUD 638.7 million, up 27.5%.
• Underlying NPAT rose 2.9% to AUD 636.8 million, while revenue climbed 5.9% to AUD 9.12 billion.
• Group operating profit increased 6.7% to AUD 813.5 million, as net investment income fell 13.9% to AUD 178.9 million.
• Final ordinary dividend set at 10.9 cps; full-year dividend lifted 6.7% to 19.2 cps, implying an 83% payout ratio.
• FY27 view: resident PHI gross margin seen broadly consistent with FY26; Medibank Health segment profit growth guided at about 25%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medibank Private Ltd. published the original content used to generate this news brief on August 19, 2026, and is solely responsible for the information contained therein.